Effects of Dual Initial Combination Therapy With Macitentan Plus Riociguat or Macitentan Plus Selexipag on Hemodynamics in Patients With Pulmonary Arterial Hypertension (SETOUCHI-PH Study)　― Protocol of a Multicenter Randomized Control Trial ―

Background: The latest guideline from the European Society of Cardiology and European Respiratory Society recommends initial combination therapy with oral pulmonary arterial hypertension (PAH)-specific drugs in PAH patients with World Health Organization functional class (WHO-FC) II or III. However,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Circ Rep
Auteurs principaux: Akagi, Satoshi, Dohi, Yoshihiro, Ishikawa, Kaori, Kubota, Kayoko, Horimoto, Koshin, Yagi, Shusuke, Hirata, Tetsuo, Yamamoto, Eiichiro, Ito, Hiroshi, Nakamura, Kazufumi
Format: Artigo
Langue:Inglês
Publié: The Japanese Circulation Society 2021
Sujets:
Protocol Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7939949/
https://ncbi.nlm.nih.gov/pubmed/33693297
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1253/circrep.CR-20-0133
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires